Thrombosis

Latest News

VTE Recurrence Risk Reduced With Rivaroxaban: Q&A With EINSTEIN CHOICE Investigator

VTE Recurrence Risk Reduced With Rivaroxaban: Q&A With EINSTEIN CHOICE Investigator

Results from the EINSTEIN CHOICE trial plus an interview with investigator Philip Stephen Wells, MD, FRCP(C), MSc.

Surgical Pulmonary Embolectomy Outcomes Not Affected by Thrombus Location

Surgical Pulmonary Embolectomy Outcomes Not Affected by Thrombus Location

Survival rates were high for patients with both central and peripheral pulmonary emboli.

Reducing Venous Thromboembolism Risk With Computerized Clinical Decision Support Systems

Reducing Venous Thromboembolism Risk With Computerized Clinical Decision Support Systems

Use of computerized clinical decision support systems significantly increased rates of appropriate VTE prophylaxis.

Intracerebral Hemorrhage: Trends in Medical Complications

Intracerebral Hemorrhage: Trends in Medical Complications

After intracerebral hemorrhage, both acute renal failure and deep venous thrombosis have increased.

Acute Ischemic Stroke: Contact Aspiration vs Stent Retriever

Acute Ischemic Stroke: Contact Aspiration vs Stent Retriever

Contact aspiration and stent retriever approaches for mechanical thrombectomy achieved similar efficacy and safety end points.

How Does Pulmonary Embolism Risk Compare After CVT vs DVT?

How Does Pulmonary Embolism Risk Compare After CVT vs DVT?

Pulmonary embolism risk after cerebral venous thromboembolism is significantly lower than after deep vein thromboembolism.

Pulmonary Embolism Adverse Events for Outpatients vs Inpatients

Pulmonary Embolism Adverse Events for Outpatients vs Inpatients

Outpatient treatment of hemodynamically stable pulmonary embolism appeared to be associated with lower rates of adverse events.

Dosing Strategy and Bleeding Risk in VTE: Is Less Frequent Injection Better?

Dosing Strategy and Bleeding Risk in VTE: Is Less Frequent Injection Better?

Patients who took enoxaparin once daily had few major bleeds compared with patients who took enoxaparin twice daily.

Venous Thromboembolism Risk Increased With Giant Cell Arteritis

Venous Thromboembolism Risk Increased With Giant Cell Arteritis

Patients with giant cell arteritis were more likely to experience venous thromboembolism during the first 3 months following diagnosis.

Sleep Apnea Increases Risk of Recurrent Pulmonary Embolism

Sleep Apnea Increases Risk of Recurrent Pulmonary Embolism

Obstructive sleep apnea is an independent risk factor for recurrent pulmonary embolism in patients who stop taking oral anticoagulation for a first episode.

Sign Up for Free e-Newsletters